Skip to main content
FinSpry Logo
FinSpry
CABA logo
CABA
(NASDAQ)
Cabaletta Bio, Inc.
$2.72-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Cabaletta Bio, Inc. (CABA) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Cabaletta Bio, Inc. stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy
Based on 8 unique analysts
(11 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$15.75
↑ 479.04% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest CABA Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

10xorbust
StockTwits
BuyInitiates Coverage
-
Douglas Tsao
HC Wainwright
BuyReiterates
-
Joshua Schimmer
Cantor Fitzgerald
BuyMaintains
$30.00
Phil Nadeau
TD Cowen
BuyMaintains
-
Michael Ulz
Morgan Stanley
BuyMaintains
$13.00
Douglas Tsao
HC Wainwright
BuyReiterates
$16.00
Sami Corwin
William Blair
BuyMaintains
-
Michael Ulz
Morgan Stanley
BuyMaintains
$13.00
Yatin Suneja
Guggenheim
BuyReiterates
$16.00
Unknown Analyst
Wells Fargo
HoldReiterates
$2.00 → $4.00
Joshua Schimmer
Cantor Fitzgerald
BuyMaintains
$30.00

Frequently Asked Questions

What is the analyst consensus rating for CABA?

The analyst consensus rating for CABA is "Buy" based on 8 analyst recommendations.

What is the average price target for CABA?

The average 12-month price target for CABA is $15.75, representing an upside of 479.0% from the current price of $2.72.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.